Pharmacology

Action Mechanism of Action Reference
RNAI INHIBITOR PCSK9 mRNA RNAi inhibitor EMA Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Cardiovascular Diseases 4 D002318 ClinicalTrials
Hyperlipoproteinemia Type II 3 D006938 ClinicalTrials
Hypercholesterolemia 3 D006937 ClinicalTrials
Hyperlipoproteinemia Type II 3 D006938 ClinicalTrials
Acute Coronary Syndrome 3 D054058 ClinicalTrials
Hyperlipidemias 1 D006949 ClinicalTrials
Kidney Diseases 1 D007674 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1639324-58-5
ChEMBL CHEMBL3990033
FDA SRS UOW2C71PG5